Perforations of the Tympanic Membrane — Clinical Documentation Guide (2026)

🔍 Definition

A tympanic membrane perforation (TMP) is a full-thickness defect in the eardrum (tympanic membrane), the thin, cone-shaped structure separating the external auditory canal from the middle ear cavity. Perforations may be acute/traumatic or chronic, and are categorized by anatomic location (central, marginal, attic/pars flaccida), size (small <25%, moderate 25–50%, subtotal 50–90%, total >90% of drum area), and laterality (FY2026 ICD-10-CM requires 5th/6th character for ear side). Loss of membrane integrity disrupts sound transmission, alters middle-ear pressure equalization, and exposes the middle ear to pathogens.

The two major clinical categories are:

• Traumatic perforation — sudden pressure change (barotrauma), direct instrumentation, acoustic trauma, or temporal bone fracture; coded under S09.2xx with appropriate 7th character.
• Non-traumatic (disease-related) perforation — complication of acute or chronic otitis media, myringitis, or iatrogenic (post-tympanostomy tube extrusion); coded under H72.x.

🗂️ Alternative Terminology

🩺 Signs & Symptoms

Clinical presentation varies by perforation type, size, and acuity. Key signs and symptoms include:

• Sudden otalgia (ear pain) — often present at time of acute/traumatic rupture, may resolve quickly
• Conductive hearing loss — magnitude correlates with perforation size and middle-ear status; must document laterality and severity (H90.0–H90.2 for conductive HL)
• Otorrhea (ear drainage) — serous, mucoid, or purulent; active drainage indicates concurrent otitis media (H66.x)
• Tinnitus — high-pitched or low-frequency ringing
• Vertigo or disequilibrium — suggests labyrinthine involvement or large perforation
• Visible defect on otoscopy — confirmed by pneumatic otoscopy or microscopy
• Sensation of blockage or fullness — pressure equalization failure
• Absent light reflex; air-fluid level behind drum — middle-ear effusion

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

The following clinical indicators should be present in documentation to support accurate coding. Absence of key elements should prompt a compliant CDI query.

🦴 Anatomy & Pathophysiology

The tympanic membrane (TM) consists of three layers: the outer squamous epithelium (continuous with the external auditory canal skin), the middle fibrous lamina propria (radial and circular collagen fibers giving structural integrity), and the inner mucosal layer (continuous with the middle-ear mucosa). The TM is anchored circumferentially to the tympanic bone via the fibrocartilaginous annulus, except at the superior pars flaccida (Shrapnell’s membrane), which lacks the fibrous middle layer and is therefore more susceptible to retraction and perforation.

The TM is divided into two regions:

• Pars tensa (lower 80%): contains all three layers; perforations here classified as central (not reaching the annulus) or marginal (touching or involving the annulus).
• Pars flaccida (Shrapnell’s membrane, upper 20%): bilaminar; attic perforations here predispose to cholesteatoma because squamous epithelium migrates medially through the defect.

Pathophysiology of perforation:

• Traumatic: Sudden pressure differential (Eustachian tube dysfunction + external pressure), direct blow, acoustic blast wave, or instrumentation disrupts the fibrous lamina, producing an irregular tear. Most traumatic perforations <50% of the pars tensa heal spontaneously within 4–8 weeks via epithelial migration.
• Infectious: Pus accumulating in the middle ear (AOM) creates pressure that ruptures the TM, typically centrally. CSOM maintains the perforation through persistent mucopurulent discharge and suppressed healing.
• Iatrogenic: Tympanostomy tubes may leave a residual perforation (rate ~2–4%) after extrusion, particularly with long-term T-tubes.

Persistent perforations impair conductive hearing by reducing the effective drum surface area, disrupt the hydraulic lever amplification of the ossicular chain, and allow pathogen entry into the normally sterile middle ear. Large perforations also impair the differential pressure effect between the oval and round windows, causing significant hearing degradation — as reported by UpToDate.

💊 Medication Impact / Treatment

Pharmacologic management of tympanic membrane perforations is largely supportive and infection-focused rather than curative:

• Topical antibiotic ear drops (e.g., ofloxacin otic, ciprofloxacin-dexamethasone) — first-line for active otorrhea through a perforation; preferred over aminoglycoside-containing drops due to potential ototoxicity when the TM is not intact. CDC antibiotic stewardship guidance emphasizes ototopical fluoroquinolones.
• Oral antibiotics (amoxicillin-clavulanate, fluoroquinolones) — for concurrent acute otitis media with systemic signs.
• Analgesics / NSAIDs — otalgia management in the acute phase.
• Antihistamines / decongestants — used in Eustachian tube dysfunction management, though evidence for healing is limited.
• Ear precautions (water precautions, no diving) — critical patient education; non-pharmacologic but clinically prescribed.
• Patch tympanoplasty / paper-patch — office-based procedure for select small perforations; not a medication but influences surgical decision-making (CPT 69610).

No medications reverse a chronic TM perforation; surgical repair (myringoplasty/tympanoplasty) remains definitive treatment for perforations failing spontaneous closure.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines (FY2026)

The following FY2026 ICD-10-CM Official Guidelines for Coding and Reporting govern tympanic membrane perforation coding:

1. Traumatic vs. non-traumatic: Acute traumatic perforations (blow to the ear, barotrauma, acoustic blast) are coded with injury codes (S09.2xx) with the appropriate 7th character — A (initial encounter), D (subsequent encounter), S (sequela). Non-traumatic/disease-related perforations use H72.x. Never code S09.2xx and H72.x for the same perforation in the same encounter.
2. Laterality (Official Guidelines, Section I.C.19.a): ICD-10-CM requires the highest level of specificity. For H72, use:
   — 5th character 0 = unspecified ear
   — 5th character 1 = right ear
   — 5th character 2 = left ear
   — 5th character 3 = bilateral (where valid)
   — Some subcategories require a 6th character for further laterality detail (e.g., H72.0x1 = central right, H72.0x2 = central left).
3. Multiple coding with otitis media: When TM perforation coexists with otitis media, assign codes for both conditions. CSOM with perforation (H66.2x) is a combination code — do NOT separately code H72.x when using H66.2x unless an independent additional perforation classification is clinically relevant and documented.
4. Cholesteatoma as complication: If cholesteatoma (H71.x) is present with marginal or attic perforation, sequence based on reason for encounter. Do not assume cholesteatoma from perforation type alone — it must be documented.
5. Traumatic perforation — 7th character assignment: Per ICD-10-CM Official Guidelines Section I.C.19.a, the 7th character A is used for the initial encounter when the patient is receiving active treatment; D for subsequent encounters; S for sequela. Sequela (e.g., persistent hearing loss) is coded with the sequela code (S09.2xxS) plus the nature-of-sequela code (H90.0x).
6. External cause codes for traumatic perforations: Assign an additional external cause code to identify mechanism:
   — Barotrauma: T70.0xxA (otitic barotrauma)
   — Acoustic trauma: T70.8xxA (other effects of noise)
   — Assault/slap: W19.xxxx or assault code as appropriate
   — Place of occurrence and activity codes as applicable.
7. Associated hearing loss: Conductive hearing loss (H90.0–H90.2) should be coded as an additional diagnosis when documented by the provider as associated with the perforation. Per AHA Coding Clinic guidance, associated conditions documented by the treating provider are reportable.

🔢 ICD-10-CM Code Set (FY2026)

🔎 Indexing

Use the FY2026 ICD-10-CM Alphabetic Index to verify correct code selection. Key index pathways:

• Perforation, tympanum → H72.9x (see subterms: central H72.0x, attic H72.1x, marginal H72.2x, multiple H72.82x, total H72.81x)
• Rupture, ear drum, traumatic → S09.2xx (with 7th character instruction)
• Otitis media, suppurative, chronic → H66.2x
• Cholesteatoma, ear → see specific site: middle ear H71.1x, external canal H71.0x, mastoid H71.2x
• Barotrauma, otic → T70.0xx
• Myringoplasty — procedural index only; see CPT section
• Hearing loss, conductive → H90.0x (bilateral), H90.1x (unilateral right), H90.2x (unilateral left)

Tabular verification: Always confirm in the ICD-10-CM Tabular List that the selected code has no “Use additional code” or “Code first” instructional notes that require a secondary code. Category H72 includes an “Excludes1” note for: traumatic rupture of ear drum (S09.2-) — confirming mutual exclusivity.

🏥 CPT (2026)

Procedure selection depends on surgical technique, extent of disease, and whether mastoidectomy is performed. The following AMA CPT 2026 codes apply:

🧾 HCPCS (2026)

📚 AHA Coding Clinic (Recent Guidance)

The following AHA Coding Clinic references provide official guidance for tympanic membrane perforation coding. Coders should verify currency with their institutional access:

• Traumatic TM perforation — 7th character selection: AHA Coding Clinic guidance confirms that the 7th character “A” (initial encounter) is used for all visits during active treatment, not just the first visit to a provider. Subsequent care after the active treatment phase uses “D.” This is particularly relevant when patients are transferred between ENT specialists for continued management.
• CSOM with and without TM perforation: AHA Coding Clinic has addressed the use of H66.2x as a combination code. When a provider documents chronic suppurative otitis media, H66.2x captures the condition. A separately documented TM perforation with distinct clinical characteristics (documented by the treating physician as a distinct condition) may be coded additionally — but coding both when perforation is simply the consequence of CSOM is not appropriate.
• Associated hearing loss coding: Coding Clinic guidance supports assignment of a conductive hearing loss code (H90.0x) as an additional diagnosis when a physician documents hearing loss in the setting of TM perforation during the same encounter.
• Cholesteatoma as complication: Cholesteatoma (H71.x) is not assumed from perforation type alone. The provider must document the diagnosis. Coding Clinic supports querying for cholesteatoma status when a marginal or attic perforation is documented without mentioning cholesteatoma.
• Post-procedural perforations: A residual TM perforation following tympanostomy tube extrusion may be coded as H72.x (appropriate subtype) when documented as a current active condition, not as a post-procedural complication code unless the provider attributes it to the procedure and the complication timeframe applies.

Note: AHA Coding Clinic subscription required for full text access at AHA Central Office. Coders should verify most recent quarterly updates.

💰 HCC / Risk Adjustment (v28)

Under the CMS-HCC Model v28 (effective for FY2026 risk adjustment), tympanic membrane perforations and related otologic conditions have limited HCC mapping:

Risk adjustment context: While TM perforations themselves carry no HCC weight under CMS-HCC v28, accurate documentation of these conditions remains important for:

• HEDIS and STAR quality measures (e.g., appropriate antibiotic prescribing)
• Surgical risk stratification and medical necessity documentation
• Comorbidity capture that may influence other HCC-mapped diagnoses (e.g., if perforation is related to immunodeficiency or autoimmune disease that IS HCC-mapped)
• Medicare Advantage chronic condition reporting requirements

✍️ CDI Query Templates

All queries below comply with ACDIS and AHIMA query standards: non-leading, multiple-choice with “other” and “clinically undetermined” options, based on clinical indicators in the record.

🧑‍⚕️ Treatments (Clinical)

Clinical management of TM perforations is stratified by acuity, size, cause, and patient factors:

Conservative Management (Watchful Waiting)

• Small traumatic perforations (<50% drum area): 80–90% heal spontaneously within 4–12 weeks with water precautions and infection prevention. Serial otoscopy with audiometry at 4–6 week intervals per American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) guidelines.
• Dry ear care: Patient education on water precautions (cotton wool + petroleum jelly earplugs when bathing; no swimming).
• Observation period: Typically 3–6 months for spontaneous closure before surgical intervention is considered.

Office-Based Procedures

• Trichloroacetic acid (TCA) cauterization of perforation edges followed by paper/fat patch placement (CPT 69610) — stimulates epithelial migration; appropriate for dry, small perforations.
• Myringotomy with tube placement (CPT 69433/69436) — for persistent middle-ear effusion with recurrent AOM; addresses Eustachian tube dysfunction underlying chronic disease.

Surgical Repair

• Myringoplasty (CPT 69620): Underlay or overlay graft technique using autologous temporalis fascia, perichondrium, or fat. Confined to drumhead; 80–95% success rates for small-to-moderate central perforations.
• Type I Tympanoplasty (CPT 69631): TM reconstruction with middle-ear exploration; indicated when middle-ear pathology suspected or when myringoplasty alone is insufficient.
• Type II–III Tympanoplasty with OCR (CPT 69632/69633): When ossicular chain disruption coexists; partial (PORP) or total (TORP) ossicular replacement prostheses.
• Tympanoplasty with mastoidectomy (CPT 69641–69646): Required when cholesteatoma is present, chronic mastoid disease exists, or repeated failed tympanoplasty.

Post-Operative Care

Standard post-operative protocol includes: ototopical antibiotic drops (fluoroquinolone), ear packing management, activity restrictions (no nose-blowing, air travel for 4–6 weeks), follow-up audiometry at 3 months per AAO-HNS clinical practice guidelines.

🎓 Patient Education / Summary

A tympanic membrane perforation is a hole in the eardrum — the thin membrane that separates the ear canal from the middle ear. It can cause pain, drainage from the ear, muffled hearing, ringing, and sometimes dizziness. Most small holes caused by sudden pressure changes or infections heal on their own within a few months. Larger holes, or holes that have been present for a long time, may require surgery to close.

Key patient education points:

• Keep the ear dry: Water in a perforated ear can carry bacteria into the middle ear and cause an infection. Use cotton wool with petroleum jelly when bathing, and avoid swimming until the hole has healed or been surgically closed.
• Do not use cotton swabs: Inserting anything into the ear canal can enlarge the perforation or introduce infection.
• Complete your antibiotics: If your doctor prescribed antibiotic ear drops, use them for the full course even if the ear feels better sooner.
• Follow-up appointments are important: Your doctor needs to monitor healing and check your hearing. Most follow-ups include a hearing test (audiometry).
• Avoid nose-blowing or diving: Pressure changes can worsen the perforation or prevent healing. Blow the nose gently with your mouth open if needed.
• Surgery is not always needed: Only perforations that do not heal on their own, cause recurring infections, or significantly affect hearing require surgery. Your doctor will discuss the options, including eardrum repair (myringoplasty) or more involved ear surgery (tympanoplasty).
• Expect gradual improvement: Hearing may be slightly muffled while the perforation is present. Most hearing returns to normal after the perforation heals. If it does not, a hearing aid evaluation may be recommended.

For more information, visit the American Academy of Otolaryngology – Head and Neck Surgery patient resources or speak with your healthcare provider.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)